Nitric oxide decreases subventricular zone stem cell proliferation by inhibition of epidermal growth factor receptor and phosphoinositide-3-kinase/Akt pathway
The FDA-approved vasopressin analogue, terlipressin (terli)in combination with albuminis recommended to treat patients (pts) with HRS-acute kidney injury (AKI)
Tight and intricate regulatory processes maintain physiological H 2 S levels, while imbalances either in its production or breakdown have deleterious consequences, with high H 2 S levels eventually becoming toxic and/or pathogenic
Carter BZ, Mak PY, Chen Y, Jacamo R, Ruvolo V, Mak DH, McQueen T, Konopleva M, Kornblau SM, Andreeff M